Neridronic acid for treating complex regional pain syndrome

CAFC
  • US 9,707,245 B2
  • Filed: 11/21/2016
  • Issued: 07/18/2017
  • Est. Priority Date: 05/14/2012
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating pain associated with complex regional pain syndrome (CRPS) comprising administering neridronic acid to a human being with CRPS, wherein bone fracture was a predisposing event for CRPS, and wherein the neridronic acid is in a salt or an acid form.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×